He is the Global AI Innovations Lead at the Coalition for Epidemic Preparedness Innovations (CEPI), where he leads the development of an end-to-end artificial intelligence platform for vaccine research and development, supporting vaccine discovery, design, and development for outbreak and epidemic response.
Previously, he served as Director of Immunoinformatics for Biologics AI at Exscientia, focusing on computational antibody design. Prior to that, he was a Scientific Leader in Computational Biophysics at GSK, contributing to vaccine development and the design of viral, bacterial, and nanoparticle targets.
He holds a PhD in Structural Biology and Biophysics from the University of Connecticut (USA), an MSPH in Epidemiology, and completed postdoctoral training in Pharmaceutical Chemistry.
His work integrates artificial intelligence, computational biophysics, and applied immunology for the development of innovative vaccines for global health.
He currently serves as Global AI Innovations Lead at CEPI (Coalition for Epidemic Preparedness Innovations).
